NCT05463289 - ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2 | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

October 29, 2025

Study Completion Date

October 29, 2025

Conditions

Type 1 DiabetesType 2 DiabetesCystic Fibrosis-related Diabetes

Interventions

DIAGNOSTIC_TEST

Point of Care Autonomous AI diabetic retinopathy exam

Participants will undergo point-of-care diabetic retinopathy screening using autonomous artificial intelligence software to interpret retinal images taken with a non-mydriatic fundus camera and providing an immediate result.

Trial Locations (1)

21287

RECRUITING

Johns Hopkins Pediatric Diabetes Center, Baltimore